Impact of antidepressants on the risk of suicide in patients with depression in real-life conditions: a decision analysis model

被引:19
作者
Cougnard, A. [1 ]
Verdoux, H. [1 ]
Grolleau, A. [1 ]
Moride, Y. [2 ]
Begaud, B. [1 ]
Tournier, M. [1 ]
机构
[1] Univ Victor Segalen Bordeaux 2, INSERM, U657, IFR Publ Hlth, Bordeaux, France
[2] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada
关键词
Antidepressant; decision analysis; depression; suicide; SEROTONIN REUPTAKE INHIBITORS; PSYCHIATRIC-DISORDER; MORTALITY; PREVALENCE; CHILDREN; THERAPY; TRIALS; ADULTS; PRIMER;
D O I
10.1017/S003329170800473X
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background. The impact of antidepressant drug treatment (ADT) on the risk of suicide is uncertain. The aim of this study was to determine in a real-life setting whether ADT is associated with an increased or a reduced risk of suicide compared to absence of ADT (no-ADT) in patients with depression. Method. A decision analysis method was used to estimate the number of suicides prevented or induced by ADT in children and adolescents (10-19 years old), adults (20-64 years old) and the elderly (>= 65 years) diagnosed with major depression. The impact of gender and parasuicide history on the findings was explored within each age group. Sensitivity analyses were used to assess the robustness of the models. Results. Prescribing ADT to all patients diagnosed with depression would prevent more than one out of three suicide deaths compared to the no-ADT strategy, irrespective of age, gender or parasuicide history. Sensitivity analyses showed that persistence in taking ADT would be the main characteristic influencing the effectiveness of ADT on suicide risk. Conclusions. Public health decisions that contribute directly or indirectly to reducing the number of patients with depression who are effectively administered ADT may paradoxically induce a rise in the number of suicides.
引用
收藏
页码:1307 / 1315
页数:9
相关论文
共 41 条
[21]   The flawed basis for FDA post-marketing safety decisions: The example of anti-depressants and children [J].
Klein, DF .
NEUROPSYCHOPHARMACOLOGY, 2006, 31 (04) :689-699
[22]  
LECADET J, 2000, PSYCHOTROPIC MED PRE
[23]   Automatic defibrillator approved for sale without prescription [J].
Lenzer, J .
BRITISH MEDICAL JOURNAL, 2004, 329 (7468) :703-703
[24]   Risk factors for suicide in China's youth: a case-control study [J].
Li, X. Y. ;
Phillips, M. R. ;
Zhang, Y. P. ;
Xu, D. ;
Yang, G. H. .
PSYCHOLOGICAL MEDICINE, 2008, 38 (03) :397-406
[25]   The long-term course of depressive disorders in the Lundby Study [J].
Mattisson, Cecilia ;
Bogren, Mats ;
Horstmann, Vibeke ;
Munk-Jorgensen, Povl ;
Nettelbladt, Per .
PSYCHOLOGICAL MEDICINE, 2007, 37 (06) :883-891
[26]   PHENOMENOLOGY OF DEPRESSION IN CHILDREN AND ADOLESCENTS [J].
MITCHELL, J ;
MCCAULEY, E ;
BURKE, PM ;
MOSS, SJ .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1988, 27 (01) :12-20
[27]   Antidepressant treatment is associated with a reduction in suicidal ideation and suicide attempts [J].
Mulder, R. T. ;
Joyce, P. R. ;
Frampton, C. M. A. ;
Luty, S. E. .
ACTA PSYCHIATRICA SCANDINAVICA, 2008, 118 (02) :116-122
[28]   Primer on medical decision analysis .3. Estimating probabilities and utilities [J].
Naglie, G ;
Krahn, MD ;
Naimark, D ;
Redelmeier, DA ;
Detsky, AS .
MEDICAL DECISION MAKING, 1997, 17 (02) :136-141
[29]  
Oh P I, 2001, Can J Clin Pharmacol, V8, P199
[30]   Antidepressant drug therapy and suicide in severely depressed children and adults - A case-control study [J].
Olfson, Mark ;
Marcus, Steven C. ;
Shaffer, David .
ARCHIVES OF GENERAL PSYCHIATRY, 2006, 63 (08) :865-872